COMMONWEALTH EQUITY SERVICES, LLC - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 54 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q3 2022$8,000
-20.0%
11,0000.0%0.00%
Q2 2022$10,0000.0%11,0000.0%0.00%
Q1 2022$10,0000.0%11,0000.0%0.00%
Q4 2021$10,0000.0%11,0000.0%0.00%
Q3 2021$10,0000.0%11,0000.0%0.00%
Q2 2021$10,0000.0%11,0000.0%0.00%
Q1 2021$10,0000.0%11,0000.0%0.00%
Q4 2020$10,0000.0%11,0000.0%0.00%
Q3 2020$10,0000.0%11,0000.0%0.00%
Q2 2020$10,0000.0%11,0000.0%0.00%
Q1 2020$10,0000.0%11,0000.0%0.00%
Q4 2019$10,000
+11.1%
11,0000.0%0.00%
Q3 2019$9,000
-10.0%
11,0000.0%0.00%
Q2 2019$10,0000.0%11,0000.0%0.00%
Q1 2019$10,000
+11.1%
11,0000.0%0.00%
Q4 2018$9,000
-10.0%
11,0000.0%0.00%
Q3 2018$10,000
-37.5%
11,000
-35.3%
0.00%
Q2 2018$16,000
+14.3%
17,0000.0%0.00%
Q1 2018$14,000
-6.7%
17,0000.0%0.00%
Q4 2017$15,00017,0000.00%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q1 2020
NameSharesValueWeighting ↓
ZAZOVE ASSOCIATES LLC 122,602,000$157,856,0006.24%
Lombard Odier Asset Management (Europe) Ltd 53,907,000$69,236,0004.40%
MACKAY SHIELDS LLC 41,286,000$52,954,0002.92%
Ferox Capital Management LP 3,500,000$4,517,0002.54%
INCOME RESEARCH & MANAGEMENT 13,354,000$17,068,0002.41%
SHENKMAN CAPITAL MANAGEMENT INC 8,715,000$11,210,0001.32%
Calamos Wealth Management LLC 2,209,000$2,828,0000.81%
Compagnie Lombard Odier SCmA 5,050,000$6,515,0000.26%
VICTORY CAPITAL MANAGEMENT INC 17,957,869$22,954,0000.16%
THRIVENT FINANCIAL FOR LUTHERANS 16,500,000$21,172,0000.12%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders